Lobbying Relationship

Client

Pfizer Inc.

More records

Lobbying firm

Empire Consulting Group

More records

  • Issues relating to prescription drug pricing; HR 1046-Medicare Negotiation and Competitive Licensing Act.

Duration: to

General Issues: Health Issues, Copyright/Patent/Trademark, Trade (Domestic & Foreign)

Spending: about $50,000 (But it's complicated. Here's why.)

Agencies lobbied since 2019: House of Representatives

Bills mentioned

H.R.1046: Medicare Negotiation and Competitive Licensing Act of 2019

Sponsor: Lloyd Doggett (D-Texas)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Mike McKay Sr. Advisor, Rep. Greg Meeks (D-NY)
Lavita Strickland LeGrys DHS-Dir/Office Leg. Affairs, Sr. Counselor/DHS Chief Procurement Officer, Sr. Adv./ Assist. Sec. Private Sector; TSA-Assist. Admin. Leg. Affairs, SBA-Cong. & Public Liaison; Sen. Feinstein (D-CA)-Jud. Counsel; Jordan Immigration Comm'n-Legal Counsel
Chaka Burgess n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page